Weight loss due to a very low calorie diet differentially affects insulin sensitivity and interleukin-6 serum levels in nondiabetic obese human subjects

Hormone and Metabolic Research

Volumn 44, Issue 6, 2012, Pages 465-470

  Oberhauser, F ^a   Schulte, D M ^a,b   Faust, M ^a   Gudelhofer H ^a   Hahn, M ^a   Muller N ^b   Neumann, K ^b   Krone, W ^a   Laudes, M ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

inflammation; metabolism; obesity

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6; LEPTIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; ELEMENTAL DIET; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT CONTENT; FEMALE; HUMAN; INSULIN SENSITIVITY; LOW CALORY DIET; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

ADIPOKINES; ADULT; BLOOD GLUCOSE; BODY COMPOSITION; BODY WEIGHT; C-REACTIVE PROTEIN; CALORIC RESTRICTION; DIABETES MELLITUS; FASTING; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; LIPID METABOLISM; MALE; OBESITY; WEIGHT LOSS;

EID: 84861700200     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1306341     Document Type: Article

References (29)

1. Fernandez-Real J M, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab: 2001; 86 1154 1159 (Pubitemid 32322997)
2. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann M M, Ristow M, Boeing H, Pfeiffer A F. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes: 2003; 52 812 817 (Pubitemid 36323590)
3. Hamid Y H, Rose C S, Urhammer S A, Glümer C, Nolsoe R, Kristiansen O P, Mandrup-Poulsen T, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia: 2005; 48 251 260 (Pubitemid 40543296)
4. Huth C, Heid I M, Vollmert C, Gieger C, Grallert H, Wolford J K, Langer B, Thorand B, Klopp N, Hamid Y H, Pedersen O, Hansen T, Lyssenko V, Groop L, Meisinger C, Döring A, Löwel H, Lieb W, Hengstenberg C, Rathmann W, Martin S, Stephens J W, Ireland H, Mather H, Miller G J, Stringham H M, Boehnke M, Tuomilehto J, Boeing H, Möhlig M, Spranger J, Pfeiffer A, Wernstedt I, Niklason A, López-Bermejo A, Fernández-Real J M, Hanson R L, Gallart L, Vendrell J, Tsiavou A, Hatziagelaki E, Humphries S E, Wichmann H E, Herder C, Illig T. IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies. Diabetes: 2006; 55 2915 2921 (Pubitemid 44923696)
5. Berthold H K, Laudes M, Krone W, Gouni-Berthold I. Association between the Interleukin-6 gene polymorphism -174G/C and serum lipoprotein (a) concentrations in humans. PLoS One: 2011; 6 e24719
6. Schultz O, Oberhauser F, Saech J, Rubbert-Roth A, Krone W, Laudes M. Inhibition of interleukin-6 signalling improves insulin sensitivity and reduces lipoprotein (a) levels in humans. PLoS One: 2010; 5 e14328
7. Ogata A, Morishima A, Hirano T, Hishitani Y, Hagihara K, Shima Y, Narazaki M, Tanaka T. Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab. Ann Rheum Dis: 2011; 70 1164 1165
8. Wallenius V, Wallenius K, Ahrén B, Rudling M, Carlsten H, Dickson S L, Ohlsson C, Jansson J O. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med: 2002; 8 75 79 (Pubitemid 34101732)
9. Di Gregorio G B, Hensley L, Lu T, Ranganathan G, Kern P A. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol Endocrinol Metab: 2004; 287 E182 E187 (Pubitemid 38856299)
10. Wunderlich F T, Ströhle P, Könner A C, Gruber S, Tovar S, Brönneke H S, Juntti-Berggren L, Li L S, van Rooijen N, Libert C, Berggren P O, Brüning J C. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab: 2010; 12 237 249
11. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta: 2011; 1813 878 888
12. Garbers C, Jänner N, Chalaris A, Moss M L, Floss D M, Meyer D, Koch-Nolte F, Rose-John S, Scheller J. Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding. J Biol Chem: 2011; 286 14804 14811
13. Rieusset J, Bouzakri K, Chevillotte E, Ricard N, Jacquet D, Bastard J P, Laville M, Vidal H. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes: 2004; 53 2232 2241 (Pubitemid 39145576)
14. Dekker M J, Lee S, Hudson R, Kilpatrick K, Graham T E, Ross R, Robinson L E. An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus. Metabolism: 2007; 56 332 338 (Pubitemid 46209224)
15. Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P, Fallucca S, Alessi E, Letizia C, Jimenez A, Fallucca F, Pugliese G. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis: 2010; 20 608 617
16. Reed J L, De Souza M J, Williams N I. Effects of exercise combined with caloric restriction on inflammatory cytokines. Appl Physiol Nutr Metab: 2010; 35 573 582
17. Finucane F M, Luan J, Wareham N J, Sharp S J, O'Rahilly S, Balkau B, Flyvbjerg A, Walker M, Hojlund K, Nolan J J. European Group for the Study of Insulin Resistance. Relationship between Insulin Sensitivity and Cardiovascular Disease Risk Study Group), Savage DB. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia: 2009; 52 2345 2349
18. Kopp H P, Kopp C W, Festa A, Krzyzanowska K, Kriwanek S, Minar E, Roka R, Schernthaner G. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol: 2003; 23 1042 1047 (Pubitemid 36713558)
19. Emery C F, Fondow M D, Schneider C M, Christofi F L, Hunt C, Busby A K, Needleman B J, Melvin W S, Elsayed-Awad H M. Gastric bypass surgery is associated with reduced inflammation and less depression: a preliminary investigation. Obes Surg: 2007; 17 759 763 (Pubitemid 46999040)
20. Manco M, Fernandez-Real J M, Equitani F, Vendrell J, Valera Mora M E, Nanni G, Tondolo V, Calvani M, Ricart W, Castagneto M, Mingrone G. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab: 2007; 92 483 490
21. Barinas-Mitchell E, Kuller L H, Sutton-Tyrrell K, Hegazi R, Harper P, Mancino J, Kelley D E. Effect of weight loss and nutritional intervention on arterial stiffness in type 2 diabetes. Diabetes Care: 2006; 29 2218 2222 (Pubitemid 44899855)
22. Martos-Moreno GÁ, Barrios V, Martínez G, Hawkins F, Argente J. Effect of weight loss on high-molecular weight adiponectin in obese children. Obesity (Silver Spring): 2010; 18 2288 2294
23. Jung S H, Park H S, Kim K S, Choi W H, Ahn C W, Kim B T, Kim S M, Lee S Y, Ahn S M, Kim Y K, Kim H J, Kim D J, Lee K W. Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss. J Nutr Biochem: 2008; 19 371 375 (Pubitemid 351695511)
24. Clifton P M, Noakes M, Keogh J, Foster P. How effective are meal replacements for treating obesity? Asia Pac J Clin Nutr: 2003; 12 Suppl S51
25. Dutheil F, Lesourd B, Courteix D, Chapier R, Doré E, Lac G. Blood lipids and adipokines concentrations during a 6-month nutritional and physical activity intervention for metabolic syndrome treatment. Lipids Health Dis: 2010; 9 148
26. Lim E L, Hollingsworth K G, Aribisala B S, Chen M J, Mathers J C, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia: 2011; 54 2506 2014
27. Heinonen M V, Laaksonen D E, Karhu T, Karhunen L, Laitinen T, Kainulainen S, Rissanen A, Niskanen L, Herzig K H. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome. Nutr Metab Cardiovasc Dis: 2009; 19 626 633
28. Savage D B, Choi C S, Samuel V T, Liu Z X, Zhang D, Wang A, Zhang X M, Cline G W, Yu X X, Geisler J G, Bhanot S, Monia B P, Shulman G I. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest: 2006; 116 817 824 (Pubitemid 43326891)
29. Samuel V T, Petersen K F, Shulman G I. Lipid-induced insulin resistance: unravelling the mechanism. Lancet: 2010; 375 2267 2277